SEC Form 4 · accession 0001179110-19-003564
Tabula Rasa HealthCare, Inc. · TRHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Calvin H Knowlton
Officer — Chief Executive Officer · Director
Period of report
Mar 7, 2019
Accepted (ET)
Mar 7, 2019 · 8:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651561
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Mar 7, 2019 | S | 4,900 | $56.76 | D | 915,675 | D | |
| Common StockF3 | Mar 7, 2019 | S | 3,100 | $57.43 | D | 912,575 | D | |
| Common Stock | holding | — | — | — | 823,917 | I | Held by spouse. | |
| Common Stock | holding | — | — | — | 10,000 | I | Held by trust for children. | |
| Common Stock | holding | — | — | — | 10,000 | I | Held by trust for children. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2018.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $56.08 to $57.07, inclusive. The reporting person undertakes to provide to Tabula Rasa HealthCare, Inc., any security holder of Tabula Rasa HealthCare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2) and (3) to this Form 4.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $57.08 to $57.83, inclusive.